AI Article Synopsis

  • The study examined how apolipoprotein E (ApoE) is involved in senile plaques in Alzheimer's disease using advanced imaging techniques on brain samples from patients with different ApoE genotypes.
  • Results showed that ApoE deposits were larger and more widely distributed than amyloid beta-protein (A beta) deposits, with some ApoE plaques occurring without any A beta presence.
  • The findings suggest that ApoE may play a unique role in the early stages of plaque formation, before substantial A beta accumulation occurs, indicating distinct stages in amyloid plaque development.

Article Abstract

In order to elucidate the mechanism of the occurrence of apolipoprotein E (ApoE) in senile plaques (SP) in the brain of Alzheimer's disease (AD) patients, we morphologically examined double immunofluorescent-stained sections by scanning with the confocal laser scan microscope (LSM) and reconstructed their three-dimensional structure by a computerized imaging technique. Brain samples were obtained from six pathologically diagnosed AD patients, including patients with the genotype ApoE epsilon 3/3 and epsilon 4/4 ApoE genotype. We found some clear differences in distribution and shape in the staining patterns of plaque-shaped deposits by ApoE antibody and amyloid beta-protein (A beta) antibody. ApoE deposits were generally larger than A beta deposits in the same region and were distributed widely at the periphery of A beta deposits. Several A beta deposits of typical, compact and primitive plaques were often included in one diffuse plaque-like deposit of ApoE. Some ApoE deposits did not exhibit any A beta-immunoreactivity. Each core represented by ApoE and A beta did not show complete overlap. Typical plaques tended to be composed mainly of A beta-immunoreactivity and had little ApoE-immunoreactivity. The discrepancy between ApoE and A beta deposition may reflect different stages of amyloidogenesis in SP. The presence of ApoE alone in plaques may represent the pathological stage before the beginning of massive A beta deposition.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0006-8993(96)01329-7DOI Listing

Publication Analysis

Top Keywords

beta deposits
12
apoe
10
senile plaques
8
alzheimer's disease
8
confocal laser
8
laser scan
8
scan microscope
8
apoe deposits
8
apoe beta
8
beta deposition
8

Similar Publications

First report of causing leaf spot of (Magnoliaceae) in China.

Plant Dis

January 2025

Huainan Normal University, School of Bioengineering, Dongshan West Road, Huainan City, Huainan, China, 232038;

Manglietia decidua is an extremely endangered species, known for its limited population and a narrow distribution range restricted to China (Yu 1994). In October 2021, a leaf disease affecting the foliage of 3-year-old M. decidua was observed at the nursery garden of the Yichun Forestry Institute of Jiangxi Province (27°55'52.

View Article and Find Full Text PDF

The deposition of amyloid-β (Aβ) aggregates and metal ions within senile plaques is a hallmark of Alzheimer's disease (AD). Among the modifications observed in Aβ peptides, -terminal truncation at Phe4, yielding Aβ, is highly prevalent in AD-affected brains and significantly alters Aβ's metal-binding and aggregation profiles. Despite the abundance of Zn(II) in senile plaques, its impact on the aggregation and toxicity of Aβ remains unexplored.

View Article and Find Full Text PDF

Myocardial fibrosis (MF) is a common pathological manifestation of many cardiovascular diseases, such as myocardial infarction, myocardial ischemia, and sudden cardiac death. It is characterized by excessive proliferation and activation of fibroblasts, transformation into myofibroblasts, and, eventually, excessive deposition of the extracellular matrix, resulting in heart damage. Currently, modern drugs such as angiotensin-converting enzyme inhibitors, diuretics, and β-blockers can improve myocardial fibrosis in clinical treatment, but their therapeutic effect on this disease is limited, with obvious side effects and high cost.

View Article and Find Full Text PDF

Although DNA methyltransferase 1 (DNMT1) and RNA editor ADAR triplications exist in Down syndrome (DS), their specific roles remain unclear. DNMT methylates DNA, yielding S-adenosine homocysteine (SAH), subsequently converted to homocysteine (Hcy) and adenosine by S-adenosine homocysteine (Hcy) hydrolase (SAHH). ADAR converts adenosine to inosine and uric acid.

View Article and Find Full Text PDF

The adenosine triphosphate-binding cassette transporter A7 (ABCA7) gene is ranked as one of the top susceptibility loci for Alzheimer's disease (AD). While ABCA7 mediates lipid transport across cellular membranes, ABCA7 loss of function has been shown to exacerbate amyloid-β (Aβ) pathology and compromise microglial function. Our family-based study uncovered an extremely rare ABCA7 p.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!